Kenowsky, S., Shao, Y., Heller, S., Golomb, J. B., Vedvyas, A., Dafflisio, G., Zhang, Q., Torossian, H., Sadowski, M. J., Wisniewski, T., Masurkar, A. V., & Reisberg, B. (2024). Nonpharmacologic Management of Behavioral and Psychological Symptoms of Dementia in Community‐Residing Persons with Moderately‐Severe Alzheimer’s Disease: One Year Results from a Randomized Controlled Trial. Alzheimer’s & Dementia, 20(S4). Portico. https://doi.org/10.1002/alz.090018

Siemers, E. R., Evans, E. E., Fisher, T. L., Boise, M., Foster, A., Leonard, J. E., Mishra, V., Mallow, C. L., Porsteinsson, A. P., Turner, R. S., Bond, W., Huffaker, J., Farlow, M. R., Honig, L. S., Sheldon, E., Townley, R. A., Winner, P., Norton, J., Holub, R., … Zauderer, M. (2024). Results of SIGNAL‐AD, a randomized, phase 1b/2 trial to evaluate safety and efficacy of targeting reactive astrocytes with pepinemab, SEMA4D blocking antibody, in people with mild Alzheimer’s dementia. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092538

Huang, A. Y., Zhou, Z., Talukdar, M., Miller, M. B., Chhouk, B., Enyenihi, L., Rosen, I., Stronge, E., Zhao, B., Kim, D., Choi, J., Khoshkhoo, S., Kim, J., Ganz, J., Travaglini, K. J., Gabitto, M. I., Hodge, R. D., Kaplan, E. S., Lein, E. S., … Walsh, C. A. (2024). Enrichment of somatic cancer driver mutations in Alzheimer’s disease microglia and its association with neuroinflammation. Alzheimer’s & Dementia, 20(S1). Portico. https://doi.org/10.1002/alz.084786

Luchsinger, J. A., Feldman, H. H., Messer, K., Edland, S. D., Leger, G. C., Jacobs, D. M., Salmon, D. P., Revta, C., Lupo, J., Durant, J., & Gibson, G. E. (2024). A Seamless Phase 2A‐Phase 2B Multi‐Center Trial to Test the Benefits of Benfotiamine on the Progression of Alzheimer’s Disease‐Benfoteam: Design and Methods. Alzheimer’s & Dementia, 20(S6). Portico. https://doi.org/10.1002/alz.091963

Telpoukhovskaia, M. A., Murdy, T. J., Marola, O. J., Charland, K., MacLean, M., Luquez, T., Lish, A. M., Neuner, S., Dunn, A., Onos, K. D., Wiley, J., Archer, D., Huentelman, M. J., Arnold, M., Menon, V., Goate, A., Van Eldik, L. J., Territo, P. R., … Howell, G. R. (2024). New directions for Alzheimer’s disease research from the Jackson Laboratory Center for Alzheimer’s and Dementia Research 2022 workshop. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(1). Portico. https://doi.org/10.1002/trc2.12458

Mitsumoto, H., Cheung, K., Oskarsson, B., Andrews, H. F., Jang, G. E., Andrews, J. A., Shah, J. S., Fernandes, J. A., McElhiney, M., & Santella, R. M. (2023). Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial. Trials, 24(1). https://doi.org/10.1186/s13063-023-07424-8

Muchtar, E., Sanchorawala, V., Hassan, H., Hegenbart, U., Schonland, S., Lee, H. C., Qazilbash, M. H., Kin, A., Houde, C. A., Buadi, F., Dispenzieri, A., Jacob, E. K., Arai, S., MD, M. C., Chakraborty, R., Lentzsch, S., Magen, H., Shkury, E., Sarubbi, C., … Gertz, M. A. (2023). The Impact of Melphalan Conditioning Schedule on Post-Transplant Outcomes in AL Amyloidosis: A Multicenter Study with 1718 Patients. Blood, 142(Supplement 1), 4784–4784. https://doi.org/10.1182/blood-2023-188115

Heuer, H. W., Clark, A. L., Brushaber, D., Forsberg, L. K., Miyagawa, T., Staffaroni, A. M., Huey, E. D., Boeve, B. F., Rosen, H. J., Boxer, A. L., & Investigators, A. (2023). Phenoconversion and disease progression observed in mutation carriers of familial Frontotemporal Lobar Degeneration in the ALLFTD Consortium. Alzheimer’s & Dementia, 19(S1). Portico. https://doi.org/10.1002/alz.068191

Ostrowitzki, S., Bittner, T., Sink, K. M., Mackey, H., Rabe, C., Honig, L. S., Cassetta, E., Woodward, M., Boada, M., van Dyck, C. H., Grimmer, T., Selkoe, D. J., Schneider, A., Blondeau, K., Hu, N., Quartino, A., Clayton, D., Dolton, M., Dang, Y., … Doody, R. S. (2022). Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease. JAMA Neurology, 79(11), 1113. https://doi.org/10.1001/jamaneurol.2022.2909

Martínez-Hernández, J., Parato, J., Sharma, A., Soleilhac, J.-M., Qu, X., Tein, E., Sproul, A., Andrieux, A., Goldberg, Y., Moutin, M.-J., Bartolini, F., & Peris, L. (2022). Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer’s disease. Frontiers in Cell and Developmental Biology, 10. https://doi.org/10.3389/fcell.2022.926914